Dr. Rachael Elizabeth Stovall is a Seattle, Washington based female rheumatologist who is specialized in Rheumatology. Active license number of Dr. Rachael Elizabeth Stovall for Rheumatology is MD61419561 in Washington. Dr. Rachael Elizabeth Stovall treat joint disease similar to orthopedists but do not perform surgeries. She diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Dr. Rachael Elizabeth Stovall speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
M.D.
Gender:
Female
Practice Address:
1959 Ne Pacific St, Seattle, Washington, 98195-0001
Phone:
206-520-5000
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1457882458
NPI Enumeration Date:
22 Mar, 2017
NPI Last Update On:
08 Jun, 2023
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Rachael Elizabeth Stovall are as mentioned below.
License Number
Specialization
State
Status
MD61419561
Rheumatologist
Washington
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Po Box 50095, Seattle, Washington
Zip:
98145-5095
Phone Number:
206-520-5700
Fax Number:
--
Patients can reach Dr. Rachael Elizabeth Stovall at 1959 Ne Pacific St, Seattle, Washington or can call to book an appointment on 206-520-5000. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.